Can Pfizer manufacture my SI product for clinical trials and scale it up for commercial launch?
We sure can. Collaborate with Pfizer CentreOne and access Pfizer’s global sites and experts, ready to support your sterile injectable’s toughest go-to-market challenges.
Kaelynn Underwood and Mckyla Chavez, Quality Control, United States
Backed by Pfizer’s resources, our collaborative approach means more efficient routes to market and high-quality sterile injectables.
You can count on us to carefully guide your compound from development through to commercial manufacture - we’ve been helping our customers overcome many technical challenges for over 40 years.
Pfizer CentreOne Manufacturing Site in Melbourne, Australia
We’re embedded within Pfizer so you’ll be supported by our team and backed by the tools, processes and experience of one of the world’s leading injectables manufacturers.
With its own portfolio of biopharmaceuticals and injectables, Pfizer continually invests in our manufacturing sites to maintain them at the cutting edge of technology.
We have regulatory knowledge on a global scale and established regulatory approvals in multiple markets including the U.S. FDA (United States), EMA (European Union), ANVISA (Brazil) and PMDA (Japan).
We’re known for our manufacturing expertise in Biologics, Small molecules, Cytotoxics (liquid), and Lyophilization.
Lyophilized product development and manufacturing is complex. We have the expertise to optimize and scale-up your lyophilization process to match the needs of your unique compound at commercial scale.
Our experts carefully consider your drug’s formulation, attributes and our lyophilization capabilities to ensure proper cycle design.
Tim Fairbanks, Pharmaceutical Attendant, United States
Manufacturing network includes:
